Skip to main navigation
Iovance Biotherapeutics
  • About
    • About Iovance Biotherapeutics
    • Management
    • Board of Directors
    • Research Partners
  • Our Technology
    • About TIL
    • Manufacturing
    • Intellectual Property
    • Publications and Scientific Presentations
  • Clinical
    • Clinical Program
      • Metastatic Melanoma
      • Cervical Carcinoma
      • Non-Small Cell Lung Cancer
      • Solid Tumors
      • Blood Cancers
    • Clinical Pipeline
    • Unmet Medical Need
    • Expanded Access Policy
  • Investors
    • Investor Overview
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Ownership Summary
      • Analyst Coverage
    • News & Events
      • Press Releases
      • Events & Presentations
    • Financial Information
      • SEC Filings
      • Financial Reports
      • Quarterly Results
      • Earnings Estimates
    • Fundamentals
      • Snapshot
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Ratios
    • Corporate Governance
      • Governance Highlights
      • Committee Composition
    • Investor Resources
      • Information Request
      • E-mail Alerts
      • IR Contacts
  • Careers
    • Why Iovance?
    • Current Job Openings
  • Patients
  • News
  • Contact

About Lion Biotech

Home Investors Governance Highlights

Governance Highlights

Governance Highlights

Governance Documents
Audit Committee Charter 36.6 KB
Code of Conduct and Ethics 97.8 KB
Nominating and Corporate Governance Committee Charter 33.1 KB
  • Investor Toolkit
  • Print Page
  • RSS
  • E-mail Alerts
  • Home
    • hidden
  • About
  • Our Technology
  • Clinical
  • Investors
  • Careers

© 2021 Iovance Biotherapeutics, Inc All Rights Reserved.

  • Privacy Policy
  • Disclaimer
  • Sitemap